TABLE 2.
Black, n (%) (n=666) |
White, n (%) (n=666) |
p-value | |
---|---|---|---|
Breast surgery | 0.028 | ||
Lumpectomy | 340 (51.1%) | 378 (56.8%) | |
Mastectomy | 324 (48.6%) | 288 (43.2%) | |
No breast surgery | 2 (0.3%) | 0 (0) | |
Axillary surgery | <0.001 | ||
SLNB | 352 (52.9%) | 438 (65.8%) | |
ALND | 297 (44.6%) | 219 (32.9%) | |
Axillary sampling | 3 (0.5%) | 0 (0) | |
NA | 14 (2.1%) | 9 (1.4%) | |
Chemotherapy | 0.004 | ||
No | 234 (35.1%) | 282 (42.3%) | |
Yes | 432 (64.9%) | 384 (57.7%) | |
Endocrine therapy | <0.001 | ||
No | 258 (38.7%) | 143 (21.5%) | |
Yes | 408 (61.3%) | 523 (78.5%) | |
Radiation therapy | 1 | ||
No | 230 (34.5%) | 232 (34.8%) | |
Yes | 422 (63.4%) | 431 (64.7%) | |
NA | 14 (2.1%) | 3 (0.5%) |
Abbreviations: SLNB, sentinel lymph node biopsy; ALND, axillary lymph node dissection; NA, not available